Krystal Biotech, Inc. (KRYS)

Krystal Biotech Revenue

Krystal Biotech had revenue of $96.04M in the quarter ending June 30, 2025, with 36.65% growth. This brings the company's revenue in the last twelve months to $359.21M, up 116.08% year-over-year. In the year 2024, Krystal Biotech had annual revenue of $290.52M with 473.02% growth.

• Revenue (ttm): $359.21M
• Revenue Growth: +116.08%
• P/S Ratio: 12.05
• Revenue / Employee: $1,306,200
• Employees: 275
• Market Cap: 4.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	290.52M	239.82M	473.02%
Dec 31, 2023	50.70M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.